Brain Metastasis of Undifferentiated Sarcoma and Response to Temozolomide Treatment -Case Report-

  • TANAKA Hirotomo
    Department of Neurosurgery, Kobe University Graduate School of Medicine
  • SASAYAMA Takashi
    Department of Neurosurgery, Kobe University Graduate School of Medicine
  • NISHIHARA Masamitsu
    Department of Neurosurgery, Kobe University Graduate School of Medicine
  • ARAI Atsushi
    Department of Neurosurgery, Kobe University Graduate School of Medicine
  • KAWAMURA Atsufumi
    Department of Neurosurgery, Hyogo Prefectural Kobe Children's Hospital
  • KANOMATA Naoki
    Department of Pathology, Kobe University Graduate School of Medicine
  • ITOH Tomoo
    Department of Pathology, Kobe University Graduate School of Medicine
  • KOHMURA Eiji
    Department of Neurosurgery, Kobe University Graduate School of Medicine

Bibliographic Information

Other Title
  • —Case Report—

Search this article

Abstract

A 33-year-old woman presented with rare brain metastases from undifferentiated high-grade sarcoma manifesting as headache and vomiting. Magnetic resonance (MR) imaging demonstrated multiple tumors in the brain, subcutaneous soft tissue, and mediastinum. The patient underwent surgery, followed by chemotherapy and radiotherapy. The histological diagnosis was undifferentiated high-grade sarcoma. Radiotherapy was effective, but the brain tumors recurred 6 months later. The patient underwent high-dose methotrexate therapy, but showed no response. Promoter hypermethylation in the O6-methylguanine-deoxyribonucleic acid methyltransferase (MGMT) genes was detected and MGMT protein expression was negative in the recurrent tumor, so temozolomide (TMZ) salvage chemotherapy was given, and follow-up MR imaging showed tumor reduction. This case suggests that TMZ may be effective for brain metastasis of undifferentiated sarcoma without MGMT protein expression.<br>

Journal

Citations (2)*help

See more

References(44)*help

See more

Details 詳細情報について

Report a problem

Back to top